Everything you need to know about TMS for Long COVID Brain Fog and Fatigue: What the Research Shows — how it works, what it costs, and how to find a provider who actually knows what they're doing.
The TMS Patient Buyer's Guide
Free 22-page guide — questions to ask, red flags, and how to choose the right provider.
Can TMS help long COVID brain fog? Maybe, but nobody can promise it yet. TMS is not FDA-cleared for long COVID, and we could not find a completed, adequately powered sham-controlled trial showing it improves brain fog or fatigue. What exists is early: a few very small studies, some retrospective clinic data, and trials still underway. If you’re living with this, you’ve probably already heard “give it time” more than once. We’ll lay out what the research does and doesn’t show so you can decide whether to pursue it, or to wait.
Key takeaways
- TMS has no FDA clearance for long COVID (also called post-COVID condition). Any use for brain fog or fatigue is off-label and experimental.
- The only sham-controlled TMS study we found for post-COVID symptoms enrolled 4 people. It is a feasibility study, not proof.
- A 2026 clinic-data study suggests depression linked to long COVID may respond less to TMS than ordinary depression.
- If you also have depression, TMS for the depression is a separate, established question. Expect the fatigue and fog to be less predictable.
- Ask any clinic offering “long COVID TMS” for the evidence behind their specific protocol. If they quote a success rate, ask where it was published.
What we know about long COVID and the brain
Long COVID is defined by symptoms continuing three months or more after the infection. Reported symptoms include fatigue, pain, cognitive problems and mood changes. One systematic review of 78 studies found significant impairments in attention, executive function and memory in people with post-COVID condition, with mixed findings on brain structure and connectivity.
The cause is still not settled. A 2026 narrative review of neurological long COVID notes that the mechanisms remain incompletely understood, and that no neurological biomarker or disease-modifying therapy has yet been clinically validated. That matters here: when a clinic says TMS “targets the cause” of brain fog, it is going beyond what anyone knows.
Why researchers are trying TMS
TMS changes activity in specific brain regions, which is why it works for depression. Researchers suspect the same approach might help circuits involved in attention, mood and fatigue after COVID. That is a hypothesis, not a result. A 2026 Tokyo clinic study describes ideas such as neuroinflammation and disrupted frontal-limbic networks as possible mechanisms, but says rTMS efficacy in this group remains uncertain.
The evidence so far
| Study type | What it found | How much weight to give it |
|---|---|---|
| Sham-controlled case series, 2024 (4 people) | iTBS was well tolerated. Trends toward improvement in cognitive interference, quality of life and anxiety in most participants | Very low. Four people, short, feasibility only |
| Systematic review, 2025 (78 studies, 8 using TMS) | Brain stimulation “showed potential benefits” for depression and cognitive problems. Authors call for further research | Low to moderate. Mostly small studies. A summary, not a verdict |
| Retrospective cohort, 2026 (44 long COVID vs 88 matched depression patients, Tokyo) | Less improvement in long COVID: MADRS improvement 38.4% vs 61.5%, remission 27.3% vs 61.4%. HAM-D response did not differ significantly | Low to moderate. Real-world data, no sham group, authors warn about confounding |
| UCLA pilot trial (NCT06586398) | A randomized, masked pilot of active versus sham rTMS for neuropsychiatric long COVID symptoms. We found no published results | Not yet usable |
Reading the table honestly:
- There’s no large randomized trial showing TMS reduces brain fog or fatigue.
- The one study with a direct comparison to ordinary depression found long COVID patients did worse on TMS. That was depression scores, not brain fog, and it was observational, so it can’t prove cause. The authors themselves caution against reading it as a causal effect.
- Trials are underway. That is good news for the future. It is not evidence you can act on today.
How to read headlines about TMS and long COVID
You may see clinic ads or news stories describing people who felt clearer after TMS. Individual stories can be real and still tell you little about whether the treatment worked. Brain fog and fatigue often fluctuate on their own, and placebo effects are strong in conditions measured by how you feel. That is exactly why sham-controlled trials matter. Until those results are in, the most accurate summary is “plausible, being tested, unproven.” A clinic that is open about that is easier to trust than one that isn’t.
If you have depression plus long COVID
Depression and anxiety are among the symptoms people with long COVID report. If you have depression that hasn’t improved with medication, TMS for depression is an established, FDA-cleared option, and our guide on TMS for treatment-resistant depression explains who qualifies. Just go in with realistic expectations. The Tokyo data suggest depression tied to long COVID may be harder to treat, and improved mood doesn’t guarantee better focus or less fatigue. Ask your clinician to track your depression and cognitive symptoms separately so you can see what changes.
We keep a short page for long COVID brain fog and depression if you want the overview.
Safety and practical points
- Screening still applies. Seizure history, metal in the head and some medications matter. Read who should not get TMS.
- Sleep and fatigue. Daily sessions take energy. If your fatigue is severe, ask about scheduling and whether travel is realistic. Our guide to TMS and sleep quality covers the sleep side.
- Memory worries. If you’re concerned about thinking and memory during treatment, see does TMS cause memory loss and TMS and cognitive function.
- Cost. Insurance coverage for TMS typically follows its cleared indications, which do not include long COVID, so ask your plan before you start and get any price in writing.
Questions to ask a clinic offering TMS for long COVID
- Is this an FDA-cleared use? (It will not be, and you should hear that plainly.)
- What protocol will you use, and where has it been studied in people with post-COVID symptoms?
- How will we measure brain fog and fatigue before, during and after? Which scales?
- What’s the total cost, and what happens if I’m not better by a set point?
- Are you part of a registered clinical trial? If so, you may not pay, and your outcomes will help future patients. You can search ClinicalTrials.gov for “post-COVID” and “transcranial magnetic stimulation.”
- Who else is overseeing my care, such as a long COVID clinic or my primary care doctor?
Our post on red flags when choosing a TMS clinic lists warning signs like guaranteed outcomes and pressure to prepay for a package.
What else to do while the research catches up
Talk to your doctor about a full evaluation of fatigue and cognitive symptoms. Other conditions can overlap with long COVID, and a clinician needs to sort that out before any brain stimulation is considered. Long COVID clinics at academic centers can also point you to trials.
If you want to explore TMS for depression or another cleared use, find a TMS clinic near you, or take the two-minute candidate quiz.
This article is general information, not medical advice.
Frequently asked questions
Is TMS FDA-cleared for long COVID?
No. TMS devices are cleared for specific conditions such as major depression and OCD, not for long COVID. Using it for brain fog or fatigue is off-label.
Does TMS help long COVID brain fog?
We don’t know. Early and very small studies hint at possible benefit, and a few trials are in progress, but we found no completed sham-controlled trial that shows it works. Treat claims of success with skepticism until results are published.
Can TMS treat long COVID fatigue?
There’s no good evidence yet. Most TMS research in this area looks at mood and cognition. Ask any clinic for published data on the exact protocol they plan to use.
Will insurance pay for TMS for long COVID?
Almost certainly not as a standalone long COVID treatment. Coverage generally follows the FDA-cleared indication, such as treatment-resistant depression. Check with your plan before you begin.
Is it safe to try TMS if I have long COVID?
TMS has a well-established safety record for its cleared uses, and the small long COVID studies reported it was well tolerated. Safety screening still applies, and long COVID adds unknowns, so go through a proper medical evaluation first.
How can I join a long COVID TMS trial?
Search ClinicalTrials.gov for post-COVID condition and transcranial magnetic stimulation, and ask your long COVID clinic or a university medical center. The UCLA pilot is one example of a registered study.
